Skip to content

BCRX

BioCryst Pharmaceuticals, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$962M+117.9%
Gross profit$941M+120.9%
Operating income−$289M—
Net income−$360M—
EPS−$1.42—
Free cash flow$366M—